tiprankstipranks
BioVaxys Technology (BVAXF)
OTHER OTC:BVAXF
US Market
BVAXF
BioVaxys Technology
RESEARCH TOOLSreports
Want to see BVAXF full AI Analyst Report?

BioVaxys Technology (BVAXF) Income Statement

32 Followers

BioVaxys Technology Income Statement

Last quarter (Q3 2025), BioVaxys Technology's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, BioVaxys Technology's net income was C$-910.06K. See BioVaxys Technology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Oct 24Jan 24Jan 23Jan 22Jan 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 3.30MC$ 2.40MC$ 4.08MC$ 6.44MC$ 1.10M
Depreciation and Amortization
C$ 0.00C$ 2.40MC$ 3.80MC$ 39.47KC$ 8.62K
EBITDA
C$ -3.95MC$ -7.69MC$ 0.00C$ -6.42MC$ -1.09M
Operating Income
C$ -3.30MC$ -2.40MC$ -4.08MC$ -6.44MC$ -1.10M
Other Income/Expenses
C$ -659.26KC$ -5.28MC$ -7.65MC$ -15.91KC$ -4.24K
Pretax Income
C$ -3.95MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.10M
Net Income
C$ -3.95MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.17M
Per Share Metrics
Basic EPS
C$ -0.20C$ -0.57C$ -1.20C$ -0.78C$ -0.42
Diluted EPS
C$ -0.20C$ -0.57C$ -1.20C$ -0.78C$ -0.42
Weighted Average Shares Outstanding
 19.57M 13.41M 9.82M 8.29M 3.00M
Weighted Average Shares Outstanding (Diluted)
 19.57M 13.41M 9.82M 8.29M 2.82M
Currency in CAD

BioVaxys Technology Earnings and Revenue History